# Kazia Therapeutics Limited — WebsDocs ASG Directory Profile

This is a public business listing published by the WebsDocs ASG Directory.
It provides machine-readable public information and static answers. It is not a live seller AI.



Canonical Directory profile:
https://directory.websdocs.com/business/kazia-therapeutics-limited

Canonical Directory JSON:
https://directory.websdocs.com/business/kazia-therapeutics-limited.json

Machine-readable public profile:
https://aig.websdocs.com/ai/kazia-therapeutics-limited/profile

Company profile JSON:
https://aig.websdocs.com/ai/kazia-therapeutics-limited/data/aig-company-profile.json

Static Agent Card:
https://aig.websdocs.com/ai/kazia-therapeutics-limited/.well-known/agent-card.json

Public discovery endpoints:
- Profile: https://aig.websdocs.com/ai/kazia-therapeutics-limited/profile
- Company JSON: https://aig.websdocs.com/ai/kazia-therapeutics-limited/data/aig-company-profile.json
- Services: https://aig.websdocs.com/ai/kazia-therapeutics-limited/services
- Offers: https://aig.websdocs.com/ai/kazia-therapeutics-limited/offers
- Schema: https://aig.websdocs.com/ai/kazia-therapeutics-limited/schema.jsonld
- Agent Card: https://aig.websdocs.com/ai/kazia-therapeutics-limited/.well-known/agent-card.json

Business summary:
Kazia is an Australian oncology company developing innovative, high-impact drugs for cancer. Our lead program is paxalisib, which is being developed to treat glioblastoma, the most common and most aggressive form of primary brain cancer in adults.

Status and boundaries:
- Directory public profile
- Customer-owned domain required: not applicable
- Active seller agent: false
- A2A messaging: unavailable
- Live reasoning or RAG: unavailable
- UCP and MCP: unavailable
- Checkout and payment execution: unavailable
- Private data access: unavailable

Use the canonical Directory profile for current public evidence.  Do not infer that a live AI Sales Gateway is active.